Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
WEX
WEX
$6.37B
| $1.3M | ﹤0.01% |
9,229
-13,330
| -59% | -$2.04M |
|
2652
Heron Therapeutics
HRTX
$93.9M
| $1.29M | ﹤0.01% |
141,864
+55,786
| +65% | +$570K |
|
|
SPNS
2653
DELISTED
Sapiens International
SPNS
| $1.29M | ﹤0.01% |
37,546
+23,974
| +177% | +$825K |
|
2654
Bank of Marin Bancorp
BMRC
$472M
| $1.28M | ﹤0.01% |
34,526
+21,615
| +167% | +$807K |
|
|
LAND
2655
Gladstone Land Corp
LAND
$350M
| $1.28M | ﹤0.01% |
38,017
+24,319
| +178% | +$655K |
|
2656
Grand Canyon Education
LOPE
$3.79B
| $1.27M | ﹤0.01% |
14,866
-56,020
| -79% | -$4.62M |
|
|
VMW
2657
PUT
DELISTED
VMware, Inc
VMW
| $1.27M | ﹤0.01% |
+11,000
| New | +$1.45M |
|
2658
Transcat
TRNS
$799M
| $1.27M | ﹤0.01% |
13,793
+7,381
| +115% | +$622K |
|
|
AJRD
2659
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.27M | ﹤0.01% |
+27,200
| New | +$1.2M |
|
2660
PUT
C.H. Robinson
CHRW
$17.4B
| $1.27M | ﹤0.01% |
11,800
| – | – |
|
2661
Monarch Casino & Resort
MCRI
$2.2B
| $1.27M | ﹤0.01% |
17,163
+1,006
| +6% | +$70.3K |
|
2662
Southern First Bancshares
SFST
$591M
| $1.27M | ﹤0.01% |
20,339
+5,994
| +42% | +$352K |
|
2663
nLIGHT
LASR
$3.88B
| $1.27M | ﹤0.01% |
52,973
+35,590
| +205% | +$939K |
|
2664
PUT
Thermo Fisher Scientific
TMO
$213B
| $1.27M | ﹤0.01% |
1,900
| – | – |
|
|
TBI
2665
Trueblue
TBI
$215M
| $1.26M | ﹤0.01% |
45,707
+17,328
| +61% | +$490K |
|
|
HT
2666
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.26M | ﹤0.01% |
137,634
-391,893
| -74% | -$3.7M |
|
2667
Yeti Holdings
YETI
$3.71B
| $1.26M | ﹤0.01% |
15,219
-95,034
| -86% | -$8.72M |
|
2668
PUT
Aflac
AFL
$64.9B
| $1.26M | ﹤0.01% |
21,500
+20,000
| +1,333% | +$1.12M |
|
2669
National Fuel Gas
NFG
$7.82B
| $1.25M | ﹤0.01% |
19,645
-50,634
| -72% | -$3.03M |
|
|
HUYA
2670
Huya Inc
HUYA
$563M
| $1.25M | ﹤0.01% |
180,631
-47,493
| -21% | -$393K |
|
2671
Inovio Pharmaceuticals
INO
$55.7M
| $1.25M | ﹤0.01% |
20,914
+13,806
| +194% | +$1.11M |
|
2672
CALL
Rio Tinto
RIO
$158B
| $1.25M | ﹤0.01% |
+18,700
| New | +$1.21M |
|
2673
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $1.25M | ﹤0.01% |
44,357
+29,422
| +197% | +$834K |
|
2674
Agnico Eagle Mines
AEM
$73.6B
| $1.24M | ﹤0.01% |
23,417
-52,859
| -69% | -$2.81M |
|
2675
LeMaitre Vascular
LMAT
$2.32B
| $1.24M | ﹤0.01% |
24,731
-3,326
| -12% | -$172K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.